Doer Biologics
Chemicals & Related Products · United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.doerbio.comRevenue
$11.1 MillionIndustry
About Doer Biologics
浙江道尔生物科技有限公司, established in April 2014, is a high-tech enterprise specializing in the development of innovative biopharmaceuticals under the East China Pharmaceutical Group. The company focuses on advanced technology platforms such as xLONGylation, MultipleBody, and AccuBody for precision cancer treatment. Their intended clients include healthcare providers and research institutions looking for cutting-edge biopharmaceutical solutions. The company has been recognized as a quasi-unicorn in Hangzhou for six consecutive years.Explore more
SIC Code 28,283NAICS Code 32,325Show moreDoer Biologics Org Chart
Compare Similar Companies to Doer Biologics
Compare insights from companies similar to Doer Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Doer Biologics Tech Stack
A closer look at the technologies used by Doer Biologics
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Doer Biologics
Sign Up For FreeTo access detailed company insights
浙江道尔生物科技有限公司, established in April 2014, is a high-tech enterprise specializing in the development of innovative biopharmaceuticals under the East China Pharmaceutical Group. The company focuses on advanced technology platforms such as xLONGylation, MultipleBody, and AccuBody for precision cancer treatment. Their intended clients include healthcare... Read More